| Unique ID issued by UMIN | UMIN000056201 |
|---|---|
| Receipt number | R000057804 |
| Scientific Title | Home-based exercise for cancer patients with chemotherapy-induced peripheral neuropathy-Feasibility Study- |
| Date of disclosure of the study information | 2024/11/19 |
| Last modified on | 2025/11/28 01:16:50 |
Home-based exercise for cancer patients with chemotherapy-induced peripheral neuropathy-Feasibility Study-
Home-based exercise for CIPN
Home-based exercise for cancer patients with chemotherapy-induced peripheral neuropathy-Feasibility Study-
Home-based exercise for CIPN-Feasibility Study-
| Japan |
Chemotherapy-induced peripheral neuropathy
| Rehabilitation medicine |
Malignancy
NO
Chemotherapy-induced peripheral neuropathy is a frequent adverse event, but there is no established treatment method yet. This study examines the tolerability of home-based exercise therapy in cancer patients with chemotherapy-induced peripheral neuropathy.
Safety
Confirmatory
Not applicable
Percentage of participation in outpatient rehabilitation sessions by physical therapists and occupational therapists
Home exercise status
Physical function
sensory function
ADL
manual dexterity
QOL
Chemotherapy Compliance
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Cancer patients undergoing outpatient treatment at National Hospital Organization Tokyo Medical Center.
Patients 20 years of age or older who have visited the outpatient clinic for rehabilitation for chemotherapy-induced peripheral neuropathy.
Patients who are able to undergo physical function assessment.
Patients who have given consent to participate in the study.
Patients with communication difficulties, such as inability to understand the purpose of the study
Patients with pre-existing or coexisting cerebrospinal and psychiatric disorders
Patients who received only speech therapy
Patients with reasons deemed inappropriate by the physician in charge
25
| 1st name | CHIEKO |
| Middle name | |
| Last name | MIYATA |
NHO Tokyo Medical Center
Palliative care and cancer rehabilitation
152-8902
Meguro-ku, Higashigaoka2-5-1, Tokyo
03-3411-0111
kuma1mie2chibi3@hosp.go.jp
| 1st name | CHIEKO |
| Middle name | |
| Last name | MIYATA |
NHO Tokyo Medical Center
Palliative care and cancer rehabilitation
152-8902
Meguro-ku, Higashigaoka2-5-1, Tokyo
03-3411-0111
kuma1mie2chibi3@yahoo.co.jp
NHO Tokyo Medical Center
Chieko Miyata
Japan Society for the Promotion of Science
Japanese Governmental office
National Hospital Organization Tokyo Medical Center
Meguro-ku, Higashigaoka2-5-1, Tokyo
03-3411-0111
rinrijm@hosp.ncgm.go.jp
NO
| 2024 | Year | 11 | Month | 19 | Day |
Published
DOI: https://www.doi.org/10.1186/s13102-025-01223-1
25
| 2025 | Year | 07 | Month | 02 | Day |
No adverse events directly attributable to the rehabilitation were observed.
Completed
| 2022 | Year | 03 | Month | 30 | Day |
| 2022 | Year | 04 | Month | 14 | Day |
| 2022 | Year | 12 | Month | 20 | Day |
| 2024 | Year | 12 | Month | 28 | Day |
| 2025 | Year | 01 | Month | 10 | Day |
| 2025 | Year | 01 | Month | 10 | Day |
| 2025 | Year | 01 | Month | 15 | Day |
Study design: prospective cohort study. Methods of recruitment: patients who visited our institution between December 2022 and February 2024 and met the selection criteria. Primary endpoints: percentage of participation in outpatient rehabilitation sessions, drop-out rate from rehabilitation. Secondary endpoints: physical function, activities of daily living, quality of life and cancer treatment compliance.
| 2024 | Year | 11 | Month | 19 | Day |
| 2025 | Year | 11 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057804